// App-Quantinova.ai

SAT0222 : HYDROXYCHLOROQUINE REDUCES THROMBOSIS (BOTH ARTERIAL AND VENOUS) IN SYSTEMIC LUPUS ERYTHEMATOSUS, PARTICULARLY IN ANTIPHOSPHOLIPID POSITIVE PATIENTS

Researchers

Presenter

  • G. Law

Principal Investigators

  • L. Magder

  • H. Fang

  • M. Petri

Medical Centers

  • Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Prednisone

  • Plaquenil

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved